CLINICAL_TRIALS
trial_result
· 2023-04-19
Clinical Trial Update: A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension [Phase 2]
Summary
Phase 2 pediatric dose-confirmation study of selexipag for pulmonary arterial hypertension has posted results; the trial is currently not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-04-19